001     155631
005     20240320115512.0
024 7 _ |a pmc:PMC8675420
|2 pmc
024 7 _ |a 10.1002/hbm.25354
|2 doi
024 7 _ |a pmid:33615640
|2 pmid
024 7 _ |a 1065-9471
|2 ISSN
024 7 _ |a 1097-0193
|2 ISSN
024 7 _ |a altmetric:100629972
|2 altmetric
037 _ _ |a DZNE-2021-00799
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Sønderby, Ida E
|0 0000-0001-7297-7855
|b 0
|e Corresponding author
245 _ _ |a Effects of copy number variations on brain structure and risk for psychiatric illness: Large-scale studies from the ENIGMA working groups on CNVs.
260 _ _ |a New York, NY
|c 2022
|b Wiley-Liss
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1655210300_927
|2 PUB:(DE-HGF)
|x Review Article
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a (CC BY)
520 _ _ |a The Enhancing NeuroImaging Genetics through Meta-Analysis copy number variant (ENIGMA-CNV) and 22q11.2 Deletion Syndrome Working Groups (22q-ENIGMA WGs) were created to gain insight into the involvement of genetic factors in human brain development and related cognitive, psychiatric and behavioral manifestations. To that end, the ENIGMA-CNV WG has collated CNV and magnetic resonance imaging (MRI) data from ~49,000 individuals across 38 global research sites, yielding one of the largest studies to date on the effects of CNVs on brain structures in the general population. The 22q-ENIGMA WG includes 12 international research centers that assessed over 533 individuals with a confirmed 22q11.2 deletion syndrome, 40 with 22q11.2 duplications, and 333 typically developing controls, creating the largest-ever 22q11.2 CNV neuroimaging data set. In this review, we outline the ENIGMA infrastructure and procedures for multi-site analysis of CNVs and MRI data. So far, ENIGMA has identified effects of the 22q11.2, 16p11.2 distal, 15q11.2, and 1q21.1 distal CNVs on subcortical and cortical brain structures. Each CNV is associated with differences in cognitive, neurodevelopmental and neuropsychiatric traits, with characteristic patterns of brain structural abnormalities. Evidence of gene-dosage effects on distinct brain regions also emerged, providing further insight into genotype-phenotype relationships. Taken together, these results offer a more comprehensive picture of molecular mechanisms involved in typical and atypical brain development. This 'genotype-first' approach also contributes to our understanding of the etiopathogenesis of brain disorders. Finally, we outline future directions to better understand effects of CNVs on brain structure and behavior.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a brain structural imaging
|2 Other
650 _ 7 |a copy number variant
|2 Other
650 _ 7 |a diffusion tensor imaging
|2 Other
650 _ 7 |a evolution
|2 Other
650 _ 7 |a genetics-first approach
|2 Other
650 _ 7 |a neurodevelopmental disorders
|2 Other
650 _ 7 |a psychiatric disorders
|2 Other
650 _ 2 |a Brain: diagnostic imaging
|2 MeSH
650 _ 2 |a Brain: growth & development
|2 MeSH
650 _ 2 |a Brain: pathology
|2 MeSH
650 _ 2 |a DNA Copy Number Variations
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Magnetic Resonance Imaging
|2 MeSH
650 _ 2 |a Mental Disorders: diagnostic imaging
|2 MeSH
650 _ 2 |a Mental Disorders: genetics
|2 MeSH
650 _ 2 |a Mental Disorders: pathology
|2 MeSH
650 _ 2 |a Multicenter Studies as Topic
|2 MeSH
650 _ 2 |a Neurodevelopmental Disorders: diagnostic imaging
|2 MeSH
650 _ 2 |a Neurodevelopmental Disorders: genetics
|2 MeSH
650 _ 2 |a Neurodevelopmental Disorders: pathology
|2 MeSH
650 _ 2 |a Neuroimaging
|2 MeSH
700 1 _ |a Ching, Christopher R K
|0 0000-0003-2921-3408
|b 1
700 1 _ |a Thomopoulos, Sophia I
|0 0000-0002-0046-4070
|b 2
700 1 _ |a van der Meer, Dennis
|b 3
700 1 _ |a Sun, Daqiang
|b 4
700 1 _ |a Villalon-Reina, Julio E
|b 5
700 1 _ |a Agartz, Ingrid
|b 6
700 1 _ |a Amunts, Katrin
|b 7
700 1 _ |a Arango, Celso
|b 8
700 1 _ |a Armstrong, Nicola J
|b 9
700 1 _ |a Ayesa-Arriola, Rosa
|b 10
700 1 _ |a Bakker, Geor
|b 11
700 1 _ |a Bassett, Anne S
|b 12
700 1 _ |a Boomsma, Dorret I
|b 13
700 1 _ |a Bülow, Robin
|b 14
700 1 _ |a Butcher, Nancy J
|b 15
700 1 _ |a Calhoun, Vince D
|b 16
700 1 _ |a Caspers, Svenja
|b 17
700 1 _ |a Chow, Eva W C
|b 18
700 1 _ |a Cichon, Sven
|b 19
700 1 _ |a Ciufolini, Simone
|b 20
700 1 _ |a Craig, Michael C
|b 21
700 1 _ |a Crespo-Facorro, Benedicto
|b 22
700 1 _ |a Cunningham, Adam C
|b 23
700 1 _ |a Dale, Anders M
|b 24
700 1 _ |a Dazzan, Paola
|b 25
700 1 _ |a de Zubicaray, Greig I
|b 26
700 1 _ |a Djurovic, Srdjan
|b 27
700 1 _ |a Doherty, Joanne L
|b 28
700 1 _ |a Donohoe, Gary
|b 29
700 1 _ |a Draganski, Bogdan
|b 30
700 1 _ |a Durdle, Courtney A
|b 31
700 1 _ |a Ehrlich, Stefan
|b 32
700 1 _ |a Emanuel, Beverly S
|b 33
700 1 _ |a Espeseth, Thomas
|b 34
700 1 _ |a Fisher, Simon E
|b 35
700 1 _ |a Ge, Tian
|b 36
700 1 _ |a Glahn, David C
|b 37
700 1 _ |a Grabe, Hans J
|0 P:(DE-2719)2811781
|b 38
|u dzne
700 1 _ |a Gur, Raquel E
|b 39
700 1 _ |a Gutman, Boris A
|b 40
700 1 _ |a Haavik, Jan
|b 41
700 1 _ |a Håberg, Asta K
|b 42
700 1 _ |a Hansen, Laura A
|b 43
700 1 _ |a Hashimoto, Ryota
|b 44
700 1 _ |a Hibar, Derrek P
|b 45
700 1 _ |a Holmes, Avram J
|b 46
700 1 _ |a Hottenga, Jouke-Jan
|b 47
700 1 _ |a Hulshoff Pol, Hilleke E
|b 48
700 1 _ |a Jalbrzikowski, Maria
|b 49
700 1 _ |a Knowles, Emma E M
|b 50
700 1 _ |a Kushan, Leila
|b 51
700 1 _ |a Linden, David E J
|b 52
700 1 _ |a Liu, Jingyu
|b 53
700 1 _ |a Lundervold, Astri J
|b 54
700 1 _ |a Martin-Brevet, Sandra
|b 55
700 1 _ |a Martínez, Kenia
|b 56
700 1 _ |a Mather, Karen A
|b 57
700 1 _ |a Mathias, Samuel R
|b 58
700 1 _ |a McDonald-McGinn, Donna M
|b 59
700 1 _ |a McRae, Allan F
|b 60
700 1 _ |a Medland, Sarah E
|b 61
700 1 _ |a Moberget, Torgeir
|b 62
700 1 _ |a Modenato, Claudia
|b 63
700 1 _ |a Monereo Sánchez, Jennifer
|b 64
700 1 _ |a Moreau, Clara A
|b 65
700 1 _ |a Mühleisen, Thomas W
|b 66
700 1 _ |a Paus, Tomas
|b 67
700 1 _ |a Pausova, Zdenka
|b 68
700 1 _ |a Prieto, Carlos
|b 69
700 1 _ |a Ragothaman, Anjanibhargavi
|b 70
700 1 _ |a Reinbold, Céline S
|b 71
700 1 _ |a Reis Marques, Tiago
|b 72
700 1 _ |a Repetto, Gabriela M
|b 73
700 1 _ |a Reymond, Alexandre
|b 74
700 1 _ |a Roalf, David R
|b 75
700 1 _ |a Rodriguez-Herreros, Borja
|b 76
700 1 _ |a Rucker, James J
|b 77
700 1 _ |a Sachdev, Perminder S
|b 78
700 1 _ |a Schmitt, James E
|b 79
700 1 _ |a Schofield, Peter R
|b 80
700 1 _ |a Silva, Ana I
|b 81
700 1 _ |a Stefansson, Hreinn
|b 82
700 1 _ |a Stein, Dan J
|b 83
700 1 _ |a Tamnes, Christian K
|b 84
700 1 _ |a Tordesillas-Gutiérrez, Diana
|b 85
700 1 _ |a Ulfarsson, Magnus O
|b 86
700 1 _ |a Vajdi, Ariana
|b 87
700 1 _ |a van 't Ent, Dennis
|b 88
700 1 _ |a van den Bree, Marianne B M
|b 89
700 1 _ |a Vassos, Evangelos
|b 90
700 1 _ |a Vázquez-Bourgon, Javier
|b 91
700 1 _ |a Vila-Rodriguez, Fidel
|b 92
700 1 _ |a Walters, G Bragi
|b 93
700 1 _ |a Wen, Wei
|b 94
700 1 _ |a Westlye, Lars T
|b 95
700 1 _ |a Wittfeld, Katharina
|0 P:(DE-2719)2810491
|b 96
|u dzne
700 1 _ |a Zackai, Elaine H
|b 97
700 1 _ |a Stefánsson, Kári
|b 98
700 1 _ |a Jacquemont, Sebastien
|b 99
700 1 _ |a Thompson, Paul M
|b 100
700 1 _ |a Bearden, Carrie E
|b 101
700 1 _ |a Andreassen, Ole A
|0 P:(DE-2719)9001146
|b 102
|u dzne
700 1 _ |a Group, ENIGMA-CNV Working
|0 P:(DE-HGF)0
|b 103
|e Collaboration Author
700 1 _ |a 2 Deletion Syndrome Working Group, ENIGMA 22q11.
|0 P:(DE-HGF)0
|b 104
|e Collaboration Author
700 1 _ |a Bernard, Manon
|b 105
700 1 _ |a Blackburn, Nicholas B
|b 106
700 1 _ |a Bøen, Rune
|b 107
700 1 _ |a de Geus, Eco
|b 108
700 1 _ |a de Zwarte, Sonja M C
|b 109
700 1 _ |a Forti, Marta Di
|b 110
700 1 _ |a Frei, Oleksandr
|b 111
700 1 _ |a Fukunaga, Masaki
|b 112
700 1 _ |a Hehir-Kwa, Jayne Y
|b 113
700 1 _ |a Hillegers, Manon H J
|b 114
700 1 _ |a Hoffmann, Per
|b 115
700 1 _ |a Homuth, Georg
|b 116
700 1 _ |a Jahanshad, Neda
|b 117
700 1 _ |a Koops, Sanne
|b 118
700 1 _ |a Kumar, Kuldeep
|b 119
700 1 _ |a Kikuchi, Masataka
|b 120
700 1 _ |a Le Hellard, Stephanie
|b 121
700 1 _ |a Leu, Costin
|b 122
700 1 _ |a Murray, Robin M
|b 123
700 1 _ |a Naerland, Terje
|b 124
700 1 _ |a Nyberg, Lars
|b 125
700 1 _ |a Ophoff, Roel A
|b 126
700 1 _ |a Pike, G Bruce
|b 127
700 1 _ |a Sando, Sigrid B
|b 128
700 1 _ |a Shin, Jean
|b 129
700 1 _ |a Shumskaya, Elena
|b 130
700 1 _ |a Sisodiya, Sanjay M
|b 131
700 1 _ |a Steen, Vidar M
|b 132
700 1 _ |a Teumer, Alexander
|b 133
700 1 _ |a Uhlmann, Anne
|b 134
700 1 _ |a Wright, Margaret J
|b 135
700 1 _ |a Antshel, Kevin M
|b 136
700 1 _ |a Campbell, Linda E
|b 137
700 1 _ |a Crossley, Nicolas A
|b 138
700 1 _ |a Crowley, T Blaine
|b 139
700 1 _ |a Daly, Eileen
|b 140
700 1 _ |a Fiksinski, Ania M
|b 141
700 1 _ |a Forsyth, Jennifer K
|b 142
700 1 _ |a Fremont, Wanda
|b 143
700 1 _ |a Goodrich-Hunsaker, Naomi J
|b 144
700 1 _ |a Gudbrandsen, Maria
|b 145
700 1 _ |a Jonas, Rachel K
|b 146
700 1 _ |a Kates, Wendy R
|b 147
700 1 _ |a Lin, Amy
|b 148
700 1 _ |a McCabe, Kathryn L
|b 149
700 1 _ |a Moss, Hayley
|b 150
700 1 _ |a Murphy, Declan G
|b 151
700 1 _ |a Murphy, Kieran C
|b 152
700 1 _ |a Owen, Michael J
|b 153
700 1 _ |a Ruparel, Kosha
|b 154
700 1 _ |a Simon, Tony J
|b 155
700 1 _ |a van Amelsvoort, Therese
|b 156
700 1 _ |a Vorstman, Jacob A S
|b 157
773 _ _ |a 10.1002/hbm.25354
|g p. hbm.25354
|0 PERI:(DE-600)1492703-2
|n 1
|p 300-328
|t Human brain mapping
|v 43
|y 2022
|x 1097-0193
856 4 _ |u https://onlinelibrary.wiley.com/doi/10.1002/hbm.25354
856 4 _ |u https://pub.dzne.de/record/155631/files/DZNE-2021-00799.pdf
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/155631/files/DZNE-2021-00799.pdf?subformat=pdfa
|x pdfa
|y OpenAccess
909 C O |o oai:pub.dzne.de:155631
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 38
|6 P:(DE-2719)2811781
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 96
|6 P:(DE-2719)2810491
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 102
|6 P:(DE-2719)9001146
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
913 0 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-344
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2022
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2022-09-27T20:46:01Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-22
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b HUM BRAIN MAPP : 2021
|d 2022-11-22
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2021-01-27
|w ger
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2022-09-27T20:46:01Z
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-22
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2022-11-22
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b HUM BRAIN MAPP : 2021
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-01-27
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2022-11-22
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-22
920 1 _ |0 I:(DE-2719)5000001
|k AG Grabe
|l Biomarkers of dementia in the general population
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)5000001
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21